Please assess the completion status of the following clinical trial:

Trial Title: OMILQ: Osteopathic Manipulation to Increase Lactation Quantity (OMILQ)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age 18 - 40~2. Between 2 and 28 weeks postpartum from a live infant birth weighing at least 2500g~3. Desire to exclusively breastfeed~4. Able to provide informed consent~5. Available for the duration of the study~6. 1 hour milk volume of less than 1oz (or 2oz for twins)~7. All current nurslings are the same age~Exclusion Criteria:~1. Current use of domperidone~2. Current use of metoclopramide~3. Current use of silymarin~4. History of breast surgery~5. Current malignancy~6. Current pulmonary embolism or deep vein thrombosis~7. Current medical condition resulting in increased intra-cranial pressure~8. History of insufficient glandular tissue (IGT)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Osteopathic Manipulation (Type: EXPERIMENTAL): This research will be carried out as a prospective, non-randomized pilot study in women aged 18-40 who are 2 weeks to 28 weeks postpartum.~The intervention investigated in this study is osteopathic manipulation.

Based on this trial design, predict the completion outcome and termination type (if applicable).